Krzysztof Mrůzek
Krzysztof Mrůzek
Research Scientist, The Ohio State University
Verified email at osumc.edu
Title
Cited by
Cited by
Year
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid†…
JC Byrd, K Mrůzek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ...
Blood 100 (13), 4325-4336, 2002
17382002
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England Journal of Medicine 371 (11), 1005-1015, 2014
8432014
Cytogenetics in acute leukemia
K Mrůzek, NA Heerema, CD Bloomfield
Blood Reviews 18 (2), 115-136, 2004
7882004
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular†…
K Mrůzek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield
Blood 109 (2), 431-448, 2007
7382007
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrůzek, D Margeson, ...
Journal of Clinical Oncology 28 (14), 2348-2355, 2010
7272010
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a Cancer†…
SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ...
Cancer Research 61 (19), 7233-7239, 2001
7092001
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B study
P Paschka, G Marcucci, AS Ruppert, K Mrůzek, H Chen, RA Kittles, ...
Journal of Clinical Oncology 24 (24), 3904-3911, 2006
7082006
MicroRNA expression in cytogenetically normal acute myeloid leukemia
G Marcucci, MD Radmacher, K Maharry, K Mrůzek, AS Ruppert, ...
New England Journal of Medicine 358 (18), 1919-1928, 2008
4842008
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia
K Mrůzek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ...
Journal of Clinical Oncology 30 (36), 4515-4523, 2012
3822012
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study
KH Metzeler, K Maharry, MD Radmacher, K Mrůzek, D Margeson, ...
Journal of Clinical Oncology 29 (10), 1373-1381, 2011
3512011
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene-and microRNA-expression†…
H Becker, G Marcucci, K Maharry, MD Radmacher, K Mrůzek, ...
Journal of Clinical Oncology 28 (4), 596-604, 2010
3472010
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience
M Wetzler, RK Dodge, K Mrůzek, AJ Carroll, R Tantravahi, AMW Block, ...
Blood 93 (11), 3983-3993, 1999
3441999
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study
G Marcucci, K Mrůzek, AS Ruppert, K Maharry, JE Kolitz, JO Moore, ...
Journal of Clinical Oncology 23 (24), 5705-5717, 2005
3362005
Clinical significance of cytogenetics in acute myeloid leukemia.
K Mrůzek, K Heinonen, A de la Chapelle, CD Bloomfield
Seminars in Oncology 24 (1), 17-31, 1997
3361997
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk†…
G Marcucci, K Maharry, MD Radmacher, K Mrůzek, T Vukosavljevic, ...
Journal of Clinical Oncology 26 (31), 5078-5087, 2008
3302008
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia†…
SS Farag, KJ Archer, K Mrůzek, AS Ruppert, AJ Carroll, JW Vardiman, ...
Blood 108 (1), 63-73, 2006
3202006
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal†…
SP Whitman, AS Ruppert, MD Radmacher, K Mrůzek, P Paschka, ...
Blood, The Journal of the American Society of Hematology 111 (3), 1552-1559, 2008
3032008
Wilms’ tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
P Paschka, G Marcucci, AS Ruppert, SP Whitman, K Mrůzek, K Maharry, ...
Journal of Clinical Oncology 26 (28), 4595-4602, 2008
2792008
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
G Marcucci, KH Metzeler, S Schwind, H Becker, K Maharry, K Mrůzek, ...
Journal of Clinical Oncology 30 (7), 742-750, 2012
2772012
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study
G Marcucci, CD Baldus, AS Ruppert, MD Radmacher, K Mrůzek, ...
Journal of Clinical Oncology 23 (36), 9234-9242, 2005
2642005
The system can't perform the operation now. Try again later.
Articles 1–20